Isolated prostate amyloidosis; a case report.
| Autor: | Sibley RR; Department of Urology, Resident (PGY-4) at Franciscan Health Olympia Fields, USA., Ellison B; OMS-II at Midwestern University (Chicago College of Osteopathic Medicine), USA., Siegert JJ; Department of Urology, Urology Program Director at Franciscan Health Olympia Fields, USA., Van Gorder MA; Pathology Consultants, Medical Director of Pathology at Franciscan Health Olympia Fields, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Urology case reports [Urol Case Rep] 2022 Sep 16; Vol. 45, pp. 102229. Date of Electronic Publication: 2022 Sep 16 (Print Publication: 2022). |
| DOI: | 10.1016/j.eucr.2022.102229 |
| Abstrakt: | Identification of amyloidosis on a prostate biopsy specimen raises suspicion for systemic amyloidosis. For patients at risk of prostate adenocarcinoma, a transrectal MRI ultrasound fusion (MRI-TRUS) guided biopsy of the prostate is often needed for further investigation. Our patient is a 70 year old male presenting from his primary care provider with an elevated PSA. The patient underwent MRI-TRUS fusion biopsy of the prostate, which demonstrated AL (lambda)-type amyloidosis, confirmed by mass spectrometry in addition to prostatic adenocarcinoma. He was subsequently diagnosed with primary amyloidosis of the prostate without evidence of other amyloid deposition sites. (© 2022 The Authors.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|